Drug Discovery Investors

This page lists investment firms that specialize in making significant investments in drug discovery companies (or specialize in the life sciences with previous successful investments in drug discovery R&D companies). This list doesn’t include all of the corporate venture arms of the major players or large established firms with smaller focus on drug discovery (e.g. Sequoia, KPCB, etc.). This also doesn’t include generalist funds that have small allocations to drug discovery companies, or specialist funds with large percentages of funds dedicated to established public companies. If you see a firm that should be included that we missed, please contact us.

Good sources for angel or seed investors in the space are Wellfound and Bay Bridge Bio’s site.

NameExample Investments
5AMIdeaya, Audentes, Achaogen
6 Dimensions CapitalBeiGene, Hua, Innovent
8VCVir, Hexagon Bio, Orca Bio
AbbVie VenturesRibometrix, Tizona, Ribon
AbingworthAlgeta, Supernus, Wilson
Advent Life SciencesArrakis, KaNDY, Amphista
AlexandriaApplied, IDEAYA, Codiak
Alta PartnersImmune Design, Vir, Zafgen
Amgen VenturesArdelyx, Ra Pharma, Surface Oncology
AnderaArtios, Arvelle, Oncoethix
Andreessen HorowitzErasca, EQRx, Tmunity
Apple Tree PartnersCorvidia, Chinook, Aileron
ARCH Venture PartnersAlnylam, Juno, Denali
Arkin HoldingsOncorus, Werewolf, Kerus
ARTIS VenturesStemCentryx, Excision, Unnatural Products
Asset Management VenturesAudentes, Esperion, Chimerix
AtlasNimbus, IFM, Padlock
Avidity BiosciencesChinook, I-Mab, Gritstone
Avoro CapitalSarepta, Mirati, Myokardia
AxialXYZPlexium, Senti, Rocket
BioMedVenturesAmal, Azafaros, Tubulis
Boxer CapitalBlack Diamond, Tango, Mirati
BVFKymera, Relay, Olema
CamberAlexion, Alkermes, Sarepta
Canaan PartnersArrakis, Novira, Civitas,
Casdin CapitalAlector, Voyager, Jounce
Codon CapitalRAPT, ORIC, Viewpoint
Column GroupFlexus, Aragon, NGM
CowenGlobal Blood Therapeutics, Nodthera, Pliant,
DCVCAbCellera, Agenovir, Recursion
Deerfield HealthcareAnnexon, Exelixis, Nektar
EcoR1Relay, Nurix, Editas
Flagship PioneeringConcert, Receptos, Tetraphase
ForbionGalapagos, Inflazome, Pieris
ForesiteThe Medicines Company, Anacor, Karyopharm
F-Prime CapitalFoldRx, Ultragenyx, Ironwood
Frazier Healthcare PartnersTularik, Array, Igynta
GatesAnacor, Immunocore, Achaogen
GeodeWave, Immunomedics, AMAG
Great Point PartnersSage Therapeutics, Igynta, Spark
GV HealthcareEditas, Schrodinger, Arcus
IkarianCuris, Morphic, Tracon
JNJ VenturesMerus, Catalyst, Aduro
Khosla VenturesEditas, Fountain, GEn1E
Kleiner PerkinsGenentech, Pharmacyclics, Flexus
Leaps by BayerArvinas, Senti, Recursion
LightstonePortola, Plexxikon, Proteolix
Lilly VenturesReceptos, Avid Radiopharmaceuticals, CGI
Logos GlobalAligos, Kymera, Olema
LongevityDecibel, ALX, UNITY
LongitudeAimmune, Jazz, KaNDY
Lux CapitalPlexium, Adimab, Magen
M Ventures (Merck KGaA)Artios, Macrophage, Plexium
MedicxiGenmab, Padlock, Synthorx
Mission BioCapitalAlector, True North, Atreca
MorningsideApellis, Kezar, CellCentric
MPM CapitalFrontier Medicines, Tizona, Repare
MRL VenturesKymera, Visterra, Xilio
ND CapitalTarveda, ARMO, Placon
New Enterprice AssociatesVertex, Ardelyx, Trillium
Nextech InvestC4, PMV, Vividion
NorthpondDiCE, Triumvira, Candel,
Novartis Venture FundAvila, FoldRx, Inflazome
Novo VenturesBolt, Escape, nKarta
Omega FundsCheckmate, Beam, Morphic
OrbimedLoxo Oncology, Alector, ORIC
Osage University PartnersLandos Biopharma, Spero Therapeutics, Synthorx
Pappas CapitalPlexxikon, Ultragenyx, Mirati
Perceptive AdvisorsBlueprint, Dova, Global Blood Therapeutics
Pfizer VenturesBioNTech, Kymera, Nimbus
Pivotal bioVenture Partners LLCKaruna Therapeutics, Inozyme, Iterum Therapeutics
Polaris PartnersAlector, Editas, Jnana
PontifaxcCAM Biotherapeutics, Silverback Therapeutics, Eloxx
Qiming USAArmo, Cadent, Kezar
Quan CapitalARMO, NextCure, Syros
RA CapitalArvinas, Ra Pharma, Moderna
RedmileRepare Therapeutics, Nurix, Lava Therapeutics
RiverVestAllakos, Lumena, Macrogenics
Roche VenturesFibrogen, Alios, Aileron
RTW InvestmentsC4, iTeos, Stoke
Rock Springs Capital LPTranslate Bio, PhaseBio
Samsara BiocapitalNura, Hookipa, Siros
SarissaIronwood, Alkermes, Jazz
Schroder AdveqAmal Therapeutics, Cedilla Therapeutics, Revolution Medicines
Scientia VenturesIntra-Cellular, Fibrogen, ADC Therapeutics
Section 32Fulcrum, Alector, EQRx
Seqouia23andMe, Stemcentrx, Cortexyme
Sofinnova VenturesSpark, Tesaro, Intellikine
Soleus CapitalBioAtla, Werewolf Therapeutics, Verona
SOSVDiCE, Candel, Vigil Neuro
SR OneDecibel, eFFECTOR, HotSpot
StonepineCatalyst, Scynexis, Amyrt
Surveyor Capital (Citadel)Spruce Biosciences, Viracta Therapeutics, Aslan
SV Health InvestorsBicycle, Sutro, Deciphera
Takeda Ventures Inc.Cortexyme, Avidity Biosciences, Heptares Therapeutics
Temasek Holdings Pvt. Ltd.Bayer, BioNTech, Cyclacel Pharmaceuticals
Third RockMyokardia, Agios, Constellation
T. Rowe PriceBeiGene, Longboard Pharmaceuticals, Kronos Bio
U.S. Venture PartnersCleave Therapeutics, Effector Therapeutics, Ribon Therapeutics
UCB BiopharmaSyndesi, Walden, Locana
venBioOlema, ALX, Akero
VenrockGilead, Millenium, Pharmacyclics
Versant VenturesJecure, Repare, Oyster Point
Vertex Ventures HCVisterra, Bicycle Therapeutics, Palleon Pharmaceuticals
Vida VenturesSutro, Dyne, Kronos
Viking GlobalPMV, Viela, Edgewise
VivoActelion, Chemocentryx, Kite
Wellington Management Company LLPAllena Pharmaceuticals, Jounce Therapeutics, Nuvation Bio
Wellington PartnersActelion, Carisma, Confo
Westlake Village BioPartnersTmunity, Arsenal, Neuron23